Hengrui Medicine (600276.SH) subsidiary's Eicosapentaenoic Acid Ethyl Ester Soft Capsules approved for listing.

As reported by the Sina Finance and Economics APP, Hengrui Medicine (600276.SH) issued an announcement recently. The company's subsidiary, Chengdu Shengdi Pharmaceutical Co., Ltd., has received a notification from the National Medical Products Administration (referred to as the "NMPA"), approving the listing of the company's Eicosapentaenoic Acid Ethyl Ester soft capsules.